The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase Ib study of PF-05082566 in combination with pembrolizumab in patients with advanced solid tumors.
 
Anthony W. Tolcher
Employment - START
Leadership - Symphony Evolution
Consulting or Advisory Role - AbbVie; Akebia Therapeutics; AP Pharma; Aragon Pharmaceuticals; ArQule; Asana Biosciences; Astellas Pharma; Astex Pharmaceuticals; AVID Radiopharmaceuticals; Bayer Schering Pharma; Bind Therapeutics; BioMed Valley Discoveries; Blend Therapeutics; Celator; Clovis Oncology; Curis; Dicerna; Eisai; Emergent BioSolutions; Heron; Janssen; Johnson & Johnson; Lilly; MedImmune; Merck Sharp & Dohme; Mersana; Merus; Nanobiotix; Novartis; Oncogenex; Pfizer; Pharmacyclics; Pierre Fabre; ProNAi; Symphony Evolution; Vaccinex; Valent Technologies; Zyngenia; Zyngenia
 
Mario Sznol
Consulting or Advisory Role - Amgen; Anaeropharma; AstraZeneca/MedImmune; Bristol-Myers Squibb; Genentech/Roche; Immune Design; Kyowa Hakko Kirin; Lion Biotechnologies; Merus; Nektar; Symphony Evolution
Other Relationship - Haymarket Media
 
Siwen Hu-Lieskovan
Honoraria - Amgen; Emergent BioSolutions; Novartis; Society for Immunotherapy of Cancer; Vaccinex
Consulting or Advisory Role - Amgen; Amgen (Inst); Emergent BioSolutions; Emergent BioSolutions (Inst); Novartis; Novartis (Inst); Society for Immunotherapy of Cancer; Society for Immunotherapy of Cancer (Inst); Vaccinex; Vaccinex (Inst)
Research Funding - Genentech (Inst); Pfizer (Inst); Plexxikon (Inst)
Travel, Accommodations, Expenses - Amgen; Emergent BioSolutions; Novartis; Vaccinex
 
Kyriakos P. Papadopoulos
Research Funding - Pfizer (Inst)
 
Amita Patnaik
Research Funding - Merck (Inst)
 
Drew W. Rasco
Research Funding - Pfizer (Inst)
 
Donna Di Gravio
Employment - Pfizer
Stock and Other Ownership Interests - Merck; Pfizer
 
Bo Huang
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
Patents, Royalties, Other Intellectual Property - Pfizer
Travel, Accommodations, Expenses - Pfizer
 
Dhiraj Gambhire
Employment - Pfizer
 
Ying Chen
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Nuzhat Pathan
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
Travel, Accommodations, Expenses - Pfizer
 
Kai Wang
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Emmett V. Schmidt
Employment - Merck
Stock and Other Ownership Interests - Merck; Merck (I)
 
Laura Quan Man Chow
Honoraria - Amgen; Astellas Pharma
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Novartis
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Lilly/ImClone (Inst); Merck (Inst); Novartis (Inst); OSI Pharmaceuticals (Inst); Pfizer (Inst); VentiRx (Inst)
Travel, Accommodations, Expenses - Merck; Novartis